202 related articles for article (PubMed ID: 3933030)
1. Experimental catalepsy is both enhanced and disrupted by apomorphine.
Klemm WR
Psychopharmacology (Berl); 1985; 87(1):12-5. PubMed ID: 3933030
[TBL] [Abstract][Full Text] [Related]
2. [Effect of repeated haloperidol and apomorphine administration on the development of tolerance for catalepsy and dopamine receptor hypersensitivity in mice].
Zharkovskiĭ AM; Matvienko OA; Nurk AM
Biull Eksp Biol Med; 1984 Oct; 98(10):444-6. PubMed ID: 6541951
[TBL] [Abstract][Full Text] [Related]
3. Cholinergic-dopaminergic interactions in experimental catalepsy.
Klemm WR
Psychopharmacology (Berl); 1983; 81(1):24-7. PubMed ID: 6415727
[TBL] [Abstract][Full Text] [Related]
4. D-1 and D-2 receptor blockade have additive cataleptic effects in mice, but receptor effects may interact in opposite ways.
Klemm WR; Block H
Pharmacol Biochem Behav; 1988 Feb; 29(2):223-9. PubMed ID: 3283778
[TBL] [Abstract][Full Text] [Related]
5. Effects of buspirone on dopamine dependent behaviours in rats.
Dhavalshankh AG; Jadhav SA; Gaikwad RV; Gaonkar RK; Thorat VM; Balsara JJ
Indian J Physiol Pharmacol; 2007; 51(4):375-86. PubMed ID: 18476392
[TBL] [Abstract][Full Text] [Related]
6. Influence of dopamine agonists and an opiate antagonist on agaricus-induced catalepsy, as tested by a new method.
Sukul NC; Klemm WR
Arch Int Pharmacodyn Ther; 1988; 295():40-51. PubMed ID: 2907723
[TBL] [Abstract][Full Text] [Related]
7. Dopaminergic and cholinergic interaction in cataleptic responses in mice.
Ushijima I; Kawano M; Kaneyuki H; Suetsugi M; Usami K; Hirano H; Mizuki Y; Yamada M
Pharmacol Biochem Behav; 1997 Sep; 58(1):103-8. PubMed ID: 9264077
[TBL] [Abstract][Full Text] [Related]
8. Post-trial dopaminergic modulation of conditioned catalepsy: A single apomorphine induced increase/decrease in dopaminergic activation immediately following a conditioned catalepsy response can reverse/enhance a haloperidol conditioned and sensitized catalepsy response.
Oliveira LR; Dias FRC; Santos BG; Silva JLL; Carey RJ; Carrera MP
Behav Brain Res; 2016 Sep; 311():87-98. PubMed ID: 27173428
[TBL] [Abstract][Full Text] [Related]
9. Effects of a novel neurotensin peptide analog given extracranially on CNS behaviors mediated by apomorphine and haloperidol.
Cusack B; Boules M; Tyler BM; Fauq A; McCormick DJ; Richelson E
Brain Res; 2000 Feb; 856(1-2):48-54. PubMed ID: 10677610
[TBL] [Abstract][Full Text] [Related]
10. Neuroleptic-induced catalepsy: a D2 blockade phenomenon?
Klemm WR
Pharmacol Biochem Behav; 1985 Dec; 23(6):911-5. PubMed ID: 2867564
[TBL] [Abstract][Full Text] [Related]
11. Potentiation of haloperidol-induced catalepsy by dopamine agonists: possible involvement of central 5-hydroxytryptamine.
Carter CJ; Pycock CJ
Pharmacol Biochem Behav; 1979 Apr; 10(4):475-80. PubMed ID: 572550
[TBL] [Abstract][Full Text] [Related]
12. Mirtazapine enhances the effect of haloperidol on apomorphine-induced climbing behaviour in mice and attenuates haloperidol-induced catalepsy in rats.
Berendsen HH; Broekkamp CL; Pinder RM
Psychopharmacology (Berl); 1998 Feb; 135(3):284-9. PubMed ID: 9498732
[TBL] [Abstract][Full Text] [Related]
13. Influences of diterpene sclareol glycol on some dopamine related behavior.
Georgieva JV
Gen Pharmacol; 1991; 22(2):331-5. PubMed ID: 2055429
[TBL] [Abstract][Full Text] [Related]
14. The neurosteroid 3 alpha-hydroxy-5 alpha-pregnan-20-one affects dopamine-mediated behavior in rodents.
Khisti RT; Deshpande LS; Chopde CT
Psychopharmacology (Berl); 2002 May; 161(2):120-8. PubMed ID: 11981591
[TBL] [Abstract][Full Text] [Related]
15. EFFECTS OF VERAPAMIL ON DOPAMINE DEPENDENT BEHAVIOURS IN RATS.
Malekar AR; Balsara JJ; Gaonkar RK
Indian J Physiol Pharmacol; 1999 Jan; 43(1):44-52. PubMed ID: 27093735
[TBL] [Abstract][Full Text] [Related]
16. Some behavioural effects of chloroquine in rats suggesting dopaminergic activation.
Amabeoku GJ
Indian J Med Res; 1994 Feb; 99():87-94. PubMed ID: 8005645
[TBL] [Abstract][Full Text] [Related]
17. Effect of piracetam, a cyclic GABA analogue, on haloperidol-induced catalepsy in the rat.
Balsara JJ; Bapat TR; Chandorkar AG
Indian J Physiol Pharmacol; 1980; 24(3):227-32. PubMed ID: 7193183
[TBL] [Abstract][Full Text] [Related]
18. Effects of L-dopa and bromocriptine on haloperidol-induced motor deficits in mice.
Kobayashi T; Araki T; Itoyama Y; Takeshita M; Ohta T; Oshima Y
Life Sci; 1997; 61(26):2529-38. PubMed ID: 9416775
[TBL] [Abstract][Full Text] [Related]
19. Reduced expression of haloperidol conditioned catalepsy in rats by the dopamine D3 receptor antagonists nafadotride and NGB 2904.
Banasikowski TJ; Beninger RJ
Eur Neuropsychopharmacol; 2012 Oct; 22(10):761-8. PubMed ID: 22410316
[TBL] [Abstract][Full Text] [Related]
20. Partial 6-hydroxydopamine-induced lesions and haloperidol-induced catalepsy.
Johnson SK; Fisher H; Wagner GC
Neuropharmacology; 1993 Mar; 32(3):273-8. PubMed ID: 8474623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
